These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group. Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798 [Abstract] [Full Text] [Related]
9. Ticarcillin/clavulanic acid versus clindamycin and gentamicin in the treatment of post-cesarean endometritis following antibiotic prophylaxis. Faro S, Martens M, Hammill H, Phillips LE, Smith D, Riddle G. Obstet Gynecol; 1989 May; 73(5 Pt 1):808-12. PubMed ID: 2704510 [Abstract] [Full Text] [Related]
14. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections. Hou F, Li J, Gao L, Chen Y. Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212 [Abstract] [Full Text] [Related]
15. Treatment of penetrating abdominal trauma and gynecologic infections. Levine DP, Wilson RF. J Reprod Med; 1988 Jun; 33(6 Suppl):598-602. PubMed ID: 3294406 [Abstract] [Full Text] [Related]
17. Parenteral beta-lactamase inhibitor combinations for clinical use. Manzella JP. Am Fam Physician; 1995 May 15; 51(7):1695-8. PubMed ID: 7754928 [Abstract] [Full Text] [Related]
18. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Clin Ther; 2006 Jan 15; 28(1):99-109. PubMed ID: 16490583 [Abstract] [Full Text] [Related]
19. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A. Am J Geriatr Pharmacother; 2004 Sep 15; 2(3):181-9. PubMed ID: 15561650 [Abstract] [Full Text] [Related]
20. Ticarcillin/clavulanate. An alternative to combination antibiotic therapy for treating soft tissue pelvic infections in women. Faro S. J Reprod Med; 1990 Mar 15; 35(3 Suppl):353-8. PubMed ID: 2181123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]